A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer

D. Castellano, P. Lianes, L. Paz-Ares, M. Hidalgo, J. A. Guerra, C. Gómez-Martín, H. Gómez, J. Calzas, H. Cortés-Funes

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences